Ureter Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    2022-02-22
    Feb 22, 2022
    F
    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    2022-01-27
    Jan 27, 2022
    U
    Completed
    • Urothelial Carcinoma
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2021-11-22
    Nov 22, 2021
    T
    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
      Teton Cancer Institute
    2021-10-04
    Oct 4, 2021
    U
    Recruiting
    • Distal Urethral Cancer
    • +8 more
    • afatinib dimaleate
    • laboratory biomarker analysis
    • Atlanta, Georgia
    • +5 more
    2021-09-24
    Sep 24, 2021
    C
    Recruiting
    • Urothelial Carcinoma
    • +4 more
    • UroCAD assay, CTU examination and urine cytology
    • Shanghai, Shanghai, China
      Changhai Hospital
    2021-09-05
    Sep 5, 2021
    M
    Recruiting
    • Urothelial Cancer
    • +3 more
    • saliva sample and questionaire
    • saliva sample, questionaire
    • Basking Ridge, New Jersey
    • +3 more
    2021-06-02
    Jun 2, 2021
    Y
    Not yet recruiting
    • Urological Malignancies
    • +4 more
      • Seoul, Korea, Republic of
        Yonsei Severance Hospital
      2020-11-10
      Nov 10, 2020
      C
      Completed
      • Healthy Subject
      • +83 more
      • educational intervention
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      2020-01-21
      Jan 21, 2020
      Y
      Recruiting
      • Prostate Cancer
      • +3 more
        • Seoul, Korea, Republic of
          Department of Urology, Urological Science Institute, Yonsei Univ
        2019-12-10
        Dec 10, 2019
        D
        Completed
        • Urothelial Carcinoma
        • +4 more
        • Copenhagen, Denmark
        • +1 more
        2019-10-07
        Oct 7, 2019
        H
        Completed
        • Bladder Cancer
        • +4 more
        • Tampa, Florida
        • +1 more
        2019-06-07
        Jun 7, 2019
        A
        Completed
        • Urinary Tract Cancer
        • +2 more
          • Amsterdam, Netherlands
            Academic Medical Center
          2018-06-05
          Jun 5, 2018
          A
          Unknown status
          • Bladder Cancer
          • +3 more
          • Treatment duration of cisplatin based chemotherapy
          • Yangsan, Gyeongsangnam-do, Korea, Republic of
          • +18 more
          2017-09-23
          Sep 23, 2017
          A
          Unknown status
          • Bladder Cancer
          • +2 more
          • Anyang, Korea, Republic of
          • +20 more
          2017-06-18
          Jun 18, 2017
          N
          Completed
          • Urothelial Carcinoma
          • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2016-11-16
          Nov 16, 2016
          A
          Unknown status
          • Transitional Cell Carcinoma of Bladder
          • +3 more
          • Tucson, Arizona
          • +15 more
          2016-04-11
          Apr 11, 2016
          M
          Completed
          • Bladder Cancer
          • +2 more
          • gemcitabine and split-dose cisplatin plus escalating doses of continuous Everolimus (RAD001)
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          2016-03-29
          Mar 29, 2016
          N
          Completed
          • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
          • +9 more
          • San Francisco, California
            UCSF-Mount Zion
          2013-06-04
          Jun 4, 2013
          N
          Completed
          • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
          • +3 more
          • arsenic trioxide
          • Chicago, Illinois
            Cancer and Leukemia Group B
          2013-06-03
          Jun 3, 2013
          A
          Completed
          • Bladder Cancer
          • Ureter Cancer
          • Genexol PM
          • Seoul, Korea, Republic of
            Asan Medical Center
          2011-12-06
          Dec 6, 2011
          A
          Completed
          • Bladder Cancer
          • +4 more
          • Palo Alto, California
          • +35 more
          2010-12-13
          Dec 13, 2010